Identification of nuclear structural protein alterations associated with seminomas

Eddy S. Leman, Ahmed Magheli, Koh Meng Aw Yong, George Netto, Stefan Hinz, Robert H. Getzenberg

Research output: Contribution to journalArticle

Abstract

Currently, there are no specific markers available for the early detection and for monitoring testicular cancer. Based upon an approach that targets nuclear structure, we have identified a set of proteins that are specific for seminomas, which may then have clinical utility for the disease. Utilizing samples obtained from men with no evidence of testicular cancer (n=5) as well as those with seminomas (n=6), nuclear matrix proteins were extracted and separated using a high-resolution two-dimensional electrophoresis gel system. The proteins were identified by mass spectrometry analysis. These analyses revealed seven nuclear matrix proteins associated with the normal testes, which did not appear in the seminomas. In the seminomas, four nuclear matrix proteins were identified to be associated with the disease that were absent in the normal testes. Mass spectrometric and immunoblot analyses of these proteins revealed that one of the proteins identified in the normal testes appears to be StAR-related lipid transfer protein 7 (StARD7). In the non-seminoma tissues, one of the identified proteins appears to be cell division protein kinase 10 (CDK10). Both StarD7 and CDK10 could potentially be involved in cell differentiation and growth, and thus may serve as potential targets for therapy of prognostication of seminomas. This is the first study to examine the role of nuclear structural proteins as potential biomarkers in testicular cancer. We are currently examining the roles of some of the identified proteins as potential biomarkers for the disease.

Original languageEnglish (US)
Pages (from-to)1274-1279
Number of pages6
JournalJournal of Cellular Biochemistry
Volume108
Issue number6
DOIs
StatePublished - Dec 15 2009

Fingerprint

Seminoma
Nuclear Proteins
Nuclear Matrix-Associated Proteins
Testicular Neoplasms
Testis
Proteins
Cell Division
Protein Kinases
Biomarkers
Electrophoresis, Gel, Two-Dimensional
Electrophoresis
Cell Differentiation
Mass Spectrometry
Mass spectrometry
Gels
Cells
Tissue
Growth
Monitoring

Keywords

  • Biomarkers
  • Nuclear matrix
  • Proteomics
  • Seminomas
  • Testicular cancer

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Leman, E. S., Magheli, A., Yong, K. M. A., Netto, G., Hinz, S., & Getzenberg, R. H. (2009). Identification of nuclear structural protein alterations associated with seminomas. Journal of Cellular Biochemistry, 108(6), 1274-1279. https://doi.org/10.1002/jcb.22357

Identification of nuclear structural protein alterations associated with seminomas. / Leman, Eddy S.; Magheli, Ahmed; Yong, Koh Meng Aw; Netto, George; Hinz, Stefan; Getzenberg, Robert H.

In: Journal of Cellular Biochemistry, Vol. 108, No. 6, 15.12.2009, p. 1274-1279.

Research output: Contribution to journalArticle

Leman, ES, Magheli, A, Yong, KMA, Netto, G, Hinz, S & Getzenberg, RH 2009, 'Identification of nuclear structural protein alterations associated with seminomas', Journal of Cellular Biochemistry, vol. 108, no. 6, pp. 1274-1279. https://doi.org/10.1002/jcb.22357
Leman, Eddy S. ; Magheli, Ahmed ; Yong, Koh Meng Aw ; Netto, George ; Hinz, Stefan ; Getzenberg, Robert H. / Identification of nuclear structural protein alterations associated with seminomas. In: Journal of Cellular Biochemistry. 2009 ; Vol. 108, No. 6. pp. 1274-1279.
@article{419e43f43e654437bef55996619fca38,
title = "Identification of nuclear structural protein alterations associated with seminomas",
abstract = "Currently, there are no specific markers available for the early detection and for monitoring testicular cancer. Based upon an approach that targets nuclear structure, we have identified a set of proteins that are specific for seminomas, which may then have clinical utility for the disease. Utilizing samples obtained from men with no evidence of testicular cancer (n=5) as well as those with seminomas (n=6), nuclear matrix proteins were extracted and separated using a high-resolution two-dimensional electrophoresis gel system. The proteins were identified by mass spectrometry analysis. These analyses revealed seven nuclear matrix proteins associated with the normal testes, which did not appear in the seminomas. In the seminomas, four nuclear matrix proteins were identified to be associated with the disease that were absent in the normal testes. Mass spectrometric and immunoblot analyses of these proteins revealed that one of the proteins identified in the normal testes appears to be StAR-related lipid transfer protein 7 (StARD7). In the non-seminoma tissues, one of the identified proteins appears to be cell division protein kinase 10 (CDK10). Both StarD7 and CDK10 could potentially be involved in cell differentiation and growth, and thus may serve as potential targets for therapy of prognostication of seminomas. This is the first study to examine the role of nuclear structural proteins as potential biomarkers in testicular cancer. We are currently examining the roles of some of the identified proteins as potential biomarkers for the disease.",
keywords = "Biomarkers, Nuclear matrix, Proteomics, Seminomas, Testicular cancer",
author = "Leman, {Eddy S.} and Ahmed Magheli and Yong, {Koh Meng Aw} and George Netto and Stefan Hinz and Getzenberg, {Robert H.}",
year = "2009",
month = "12",
day = "15",
doi = "10.1002/jcb.22357",
language = "English (US)",
volume = "108",
pages = "1274--1279",
journal = "Journal of Cellular Biochemistry",
issn = "0730-2312",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Identification of nuclear structural protein alterations associated with seminomas

AU - Leman, Eddy S.

AU - Magheli, Ahmed

AU - Yong, Koh Meng Aw

AU - Netto, George

AU - Hinz, Stefan

AU - Getzenberg, Robert H.

PY - 2009/12/15

Y1 - 2009/12/15

N2 - Currently, there are no specific markers available for the early detection and for monitoring testicular cancer. Based upon an approach that targets nuclear structure, we have identified a set of proteins that are specific for seminomas, which may then have clinical utility for the disease. Utilizing samples obtained from men with no evidence of testicular cancer (n=5) as well as those with seminomas (n=6), nuclear matrix proteins were extracted and separated using a high-resolution two-dimensional electrophoresis gel system. The proteins were identified by mass spectrometry analysis. These analyses revealed seven nuclear matrix proteins associated with the normal testes, which did not appear in the seminomas. In the seminomas, four nuclear matrix proteins were identified to be associated with the disease that were absent in the normal testes. Mass spectrometric and immunoblot analyses of these proteins revealed that one of the proteins identified in the normal testes appears to be StAR-related lipid transfer protein 7 (StARD7). In the non-seminoma tissues, one of the identified proteins appears to be cell division protein kinase 10 (CDK10). Both StarD7 and CDK10 could potentially be involved in cell differentiation and growth, and thus may serve as potential targets for therapy of prognostication of seminomas. This is the first study to examine the role of nuclear structural proteins as potential biomarkers in testicular cancer. We are currently examining the roles of some of the identified proteins as potential biomarkers for the disease.

AB - Currently, there are no specific markers available for the early detection and for monitoring testicular cancer. Based upon an approach that targets nuclear structure, we have identified a set of proteins that are specific for seminomas, which may then have clinical utility for the disease. Utilizing samples obtained from men with no evidence of testicular cancer (n=5) as well as those with seminomas (n=6), nuclear matrix proteins were extracted and separated using a high-resolution two-dimensional electrophoresis gel system. The proteins were identified by mass spectrometry analysis. These analyses revealed seven nuclear matrix proteins associated with the normal testes, which did not appear in the seminomas. In the seminomas, four nuclear matrix proteins were identified to be associated with the disease that were absent in the normal testes. Mass spectrometric and immunoblot analyses of these proteins revealed that one of the proteins identified in the normal testes appears to be StAR-related lipid transfer protein 7 (StARD7). In the non-seminoma tissues, one of the identified proteins appears to be cell division protein kinase 10 (CDK10). Both StarD7 and CDK10 could potentially be involved in cell differentiation and growth, and thus may serve as potential targets for therapy of prognostication of seminomas. This is the first study to examine the role of nuclear structural proteins as potential biomarkers in testicular cancer. We are currently examining the roles of some of the identified proteins as potential biomarkers for the disease.

KW - Biomarkers

KW - Nuclear matrix

KW - Proteomics

KW - Seminomas

KW - Testicular cancer

UR - http://www.scopus.com/inward/record.url?scp=71749106742&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71749106742&partnerID=8YFLogxK

U2 - 10.1002/jcb.22357

DO - 10.1002/jcb.22357

M3 - Article

VL - 108

SP - 1274

EP - 1279

JO - Journal of Cellular Biochemistry

JF - Journal of Cellular Biochemistry

SN - 0730-2312

IS - 6

ER -